novel kinase inhibitor promising in nsclc
Published 13 years ago • 355 plays • Length 3:57Download video MP4
Download video MP3
Similar videos
-
10:57
molecular clues help refine kinase inhibitor strategy for gi
-
1:18
elucidating novel targets in nsclc
-
0:55
tyrosine kinase inhibitors
-
4:50
the development of ret novel kinase inhibitor by devon simhony
-
2:14
novel immunotherapy and small molecule inhibitor combinations
-
2:54
pembrolizumab or egfr tyrosine kinase inhibitors in nsclc?
-
4:25
causes of constant phlegmy throat or throat mucus
-
21:14
anticancer small molecular inhibitors
-
35:08
cancer survivor story: my successful targeted therapy treatment | ashley's story (2 of 3)
-
1:21
immunotherapy-chemo offers survival advantage in low pd-l1 nsclc - medpage today
-
2:20
osimertinib in advanced non–small-cell lung cancer
-
5:40
nsclc: promising molecular targets
-
3:30
favorable safety profile in novel trk inhibitor
-
5:04
gefitinib: inhibitor of egfr tyrosine kinase mutants in nsclc
-
13:06
noemi reguart, esmo 2019 - egfr tyrosine kinase inhibitors in nsclc
-
2:48
targeted therapy resistance mechanisms in alk nsclc
-
2:01
antibody arrays to assess resistance to tyrosine kinase inhibitors | protocol preview
-
1:52
dr. drilon on the utility of brigatinib in alk nsclc
-
6:17
introduction to alk inhibitors
-
10:10
development of novel met inhibitors by jessa na
-
0:30
emerging data on immunotherapies and tyrosine kinase inhibitors in lung cancer: 2022 esmo florida
-
6:05
adaura: extremely positive data in early nsclc, but questions remain - medpage today